Related by context. Frequent words. (Click for all words.) 61 EPIX Pharmaceuticals Inc. 59 Inc Therapeutic Competitors 59 Presents Positive 59 Inc. Nasdaq IMGN 58 Indevus Pharmaceuticals 58 Nasdaq BIIB 58 Idera Pharmaceuticals 58 Oxigene 58 Nasdaq ALTH 58 Inc. NASDAQ MRNA 58 Vicuron Pharmaceuticals 56 Synta Pharmaceuticals Corp. 56 Q2 Loss Narrows 56 Neurobiological Technologies Inc. 56 CRXX 56 Genelabs Technologies Inc. 56 Somaxon Pharmaceuticals Inc. 56 Regains Compliance With 56 OSIR 56 Vanda Pharmaceuticals Inc. 55 EPIX Pharmaceuticals 55 Avanir Pharmaceuticals 55 MNTA 55 Indevus Pharmaceuticals Inc. 55 Coley Pharmaceutical Group 55 Announces Publication 55 ENZN 55 Transkaryotic Therapies Inc. 55 Completes Enrollment 55 Nasdaq VRTX 55 Q1 Loss Narrows 55 NASDAQ SHPGY 55 Altus Pharmaceuticals 55 Inc. NASDAQ VVUS 55 Q2 Loss Widens 54 NASDAQ IMCL 54 Regains Compliance 54 NASDAQ ARIA 54 NASDAQ AMAG 54 NitroMed 54 Penwest Pharmaceuticals Co. 54 Announces Presentation 54 Altus Pharmaceuticals Inc. 54 Q3 Loss Narrows 54 Q4 Loss Widens 54 Corporation NASDAQ GENZ 54 AVEO Pharmaceuticals 54 VIA Pharmaceuticals 54 Stockholders Approve 54 Transkaryotic 54 Barrier Therapeutics Inc. 54 Transcept Pharmaceuticals Inc. 54 Javelin Pharmaceuticals 54 NYSE MYL 54 Nasdaq ASTM 53 Threshold Pharmaceuticals 53 Actelion Ltd 53 Webcast Annual Meeting 53 Company Nasdaq PRGO 53 Skymark Research Initiates Independent 53 Completes Tender Offer 53 Idenix Pharmaceuticals 53 Initiates Phase 53 DepoMed 53 Unigene Laboratories Inc. 53 AMAG Pharmaceuticals Inc. 53 Avalon Pharmaceuticals 53 Q3 Loss Widens 53 SUPG 53 Ironwood Pharmaceuticals Inc. 53 Flamel Technologies SA 53 Synta Pharmaceuticals 53 Files Registration Statement 53 BioMimetic Therapeutics Inc. 53 AVEO Pharmaceuticals Inc. 53 Xenoport 53 Andrx Corporation 53 CEO Exercises Options 53 Files Annual Report 53 Progenics Pharmaceuticals 53 PROFILE CO 53 ICOS Corporation 53 Inc. NASDAQ POZN 52 Host Fourth Quarter 52 Adeona Pharmaceuticals Inc. 52 Sunesis Pharmaceuticals 52 FDA Accepts 52 Molecular Insight Pharmaceuticals 52 Alseres Pharmaceuticals Inc. 52 RegeneRx Biopharmaceuticals Inc. 52 Extends Tender Offer 52 Adopts Shareholder Rights 52 Inc. NasdaqGM 52 TorreyPines Therapeutics 52 Healthnostics Inc. 52 Q4 Loss Narrows 52 Lexicon Pharmaceuticals 52 NASDAQ DYAX 52 NASDAQ STEM 52 Trubion Pharmaceuticals Inc. 52 Repligen Corporation